VIEWPOINTS Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022BySenior EditorAugust 23, 20220Comments
VIEWPOINTS Michael G. Chez and Greg Grunberg Share Insights from “The Care Giver” Series Based on EpilepsyBySenior EditorAugust 22, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in July 2022BySenior EditorAugust 18, 20220Comments
VIEWPOINTS Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With OsteopeniaBySenior EditorAugust 17, 20220Comments
VIEWPOINTS Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic ScienceBySenior EditorAugust 16, 20220Comments
TOP 20 Top 20 Immunology Companies Based on 2021 Immunology Segment Total RevenueByPrince GiriAugust 11, 20220Comments
VIEWPOINTS PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle TherapyBySenior EditorAugust 10, 20220Comments
THOUGHTSPOT The Emergence of Artificial Intelligence in the Pharmaceutical IndustryBySenior EditorAugust 9, 20220Comments
